Reproducibility and changes in vena caval blood flow by using 4D flow MRI in pulmonary emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD substudy

Ozair Rahman, Michael Markl*, Pallavi Balte, Haben Berhane, Carmen Blanken, Kenichiro Suwa, Stephen Dashnaw, Oliver Wieben, David A. Bluemke, Martin R. Prince, Joao Lima, Erin Michos, Bharath Ambale-Venkatesh, Eric A. Hoffman, Antoinette S. Gomes, Karol Watson, Yanping Sun, James Carr, R. Graham Barr

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is associated with hemodynamic changes in the pulmonary vasculature. However, cardiac effects are not fully understood and vary by phenotype of chronic lower respiratory disease. Purpose: To use four-dimensional (4D) flow MRI for comprehensive assessment of the right-sided cardiovascular system, assess its interrater and intraobserver reproducibility, and examine associations with venous return to the right heart in individuals with chronic COPD and emphysema. Materials and Methods: The Multi-Ethnic Study of Atherosclerosis COPD substudy prospectively recruited participants who smoked and who had COPD and nested control participants from population-based samples. Electrocardiography and respiratory gated 4D flow 1.5-T MRI was performed at three sites with full volumetric coverage of the thoracic vessels in 2014-2017 with postbronchodilator spirometry and inspiratory chest CT to quantify percent emphysema. Net flow, peak velocity, retrograde flow, and retrograde fraction were measured on 14 analysis planes. Interrater reproducibility was assessed by two independent observers, and the principle of conservation of mass was employed to evaluate the internal consistency of flow measures. Partial correlation coefficients were adjusted for age, sex, race/ethnicity, height, weight, and smoking status. Results: Among 70 participants (29 participants with COPD [mean age, 73.5 years 6 8.1 {standard deviation}; 20 men] and 41 control participants [mean age, 71.0 years 6 6.1; 22 men]), the interrater reproducibility of the 4D flow MRI measures was good to excellent (intraclass correlation coefficient range, 0.73-0.98), as was the internal consistency. There were no statistically significant differences in venous flow parameters according to COPD severity (P .05). Greater percent emphysema at CT was associated with greater regurgitant flow in the superior and inferior caval veins and tricuspid valve (adjusted r = 0.28-0.55; all P , .01), particularly in the superior vena cava. Conclusion: Four-dimensional flow MRI had good-to-excellent observer variability and flow consistency. Percent emphysema at CT was associated with statistically significant differences in retrograde flow, greatest in the superior vena cava.

Original languageEnglish (US)
Pages (from-to)585-594
Number of pages10
JournalRadiology
Volume292
Issue number3
DOIs
StatePublished - 2019

Funding

Disclosures of Conflicts of Interest: O.R. disclosed no relevant relationships. M.M. disclosed no relevant relationships. P.B. disclosed no relevant relationships. H.B. disclosed no relevant relationships. C.B. disclosed no relevant relationships. K.S. disclosed no relevant relationships. S.D. disclosed no relevant relationships. O.W. disclosed no relevant relationships. D.A.B. disclosed no relevant relationships. M.R.P. disclosed no relevant relationships. J.L. disclosed no relevant relationships. E.M. disclosed no relevant relationships. B.A.V. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money paid to author for consultancy from Biomet; money to author’s institution for grants/grants pending from Canon Medical Systems and Maryland Innovation Initiative. Other relationships: disclosed no relevant relationships. E.A.H. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed that author is a founder and shareholder in Vida Diagnostics. Other relationships: disclosed no relevant relationships. A.S.G. disclosed no relevant relationships. K.W. disclosed no relevant relationships. Y.S. disclosed no relevant relationships. J.C. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money paid to author for board memberships from Bayer, Guerbet, Siemens, GE Healthcare; disclosed money to author’s institution from Bayer, Guerbet; disclosed money to author for payment for lectures including service on speakers’ bureaus from Bayer, Guerbet. Other relationships: disclosed no relevant relationships. R.G.B. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money to author’s institution for grant from National Institutes of Health; disclosed reimbursement for travel from the COPD Foundation. Other relationships: disclosed no relevant relationships. Study procedures were approved by institutional review boards of the participating institutions and by the National Heart, Lung, and Blood Institute. Written informed consent and Health Insurance Portability and Accountability Act approval were obtained from all participants. The study was funded by the National Heart, Lung, and Blood Institute. Study supported by MESA (UL1-RR024156), National Institutes of Health Clinical Center (R01-HL077612, R01-HL093081), National Institutes of Health/ National Heart, Lung, and Blood Institute (N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169), and National Center for Research Resources (UL1-TR-000040, UL1-TR-001079).

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Reproducibility and changes in vena caval blood flow by using 4D flow MRI in pulmonary emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD substudy'. Together they form a unique fingerprint.

Cite this